Cybrexa Therapeutics

Developer of therapeutics that target the tumour microenvironment

placeNew Haven, Connecticut, United States calendar_todayFounded 2016 groups19 employees language cybrexa.com

Registered entities

Investor mix

6 investors on record; lead investors include Connecticut Innovations, Cycle Capital, HighCape Capital, Elm Street Ventures.

Investor typeCountShare
Venture capital350%
Private equity233%
Other / undisclosed117%
Coming soon